ADMA · Adma Biologics, Inc.
Market Cap
$2.09B
Shares
223.98M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-22 | 384 | $8.59 | $3,299 |
| 2026-07-20 | 1,762 | $8.71 | $15,347 |
| 2026-07-17 | 8,863 | $8.81 | $78,083 |
| 2026-07-15 | 4,533 | $8.87 | $40,208 |
| 2026-07-01 | 5 | $8.37 | $42 |
| 2026-06-30 | 20,721 | $8.37 | $173,435 |
| 2026-06-25 | 5,198 | $8.70 | $45,223 |
| 2026-06-24 | 5,449 | $8.69 | $47,352 |
| 2026-06-18 | 477 | $8.42 | $4,016 |
| 2026-06-12 | 1,597 | $8.32 | $13,287 |
| 2026-06-09 | 79 | $8.06 | $637 |
| 2026-06-08 | 40,067 | $7.97 | $319,334 |
| 2026-06-01 | 444 | $7.98 | $3,543 |
Showing 1–13 of 13 settlements
Key facts
CIK
1368514
CUSIP
000899104
13F (30d)
252 filings
248 filers
Visit website
Investor relations